CliffBio
small molecule

OXYTOCIN

OXYTOCIN

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameOXYTOCIN
Active ingredientOXYTOCIN
Strength300USP UNITS/30ML (10USP UNITS/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJuly 2007
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.